[x]
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
For the quarterly period ended
April 27, 2008
|
[_]
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
Delaware
|
94-3177549
|
(State
or Other Jurisdiction of
|
(I.R.S.
Employer
|
Incorporation
or Organization)
|
Identification
No.)
|
Large accelerated filer x | Accelerated filer o |
Non-accelerated filer o (Do not check if a smaller reporting company) | Smaller reporting company o |
Page
|
||
PART
I :
FINANCIAL INFORMATION
|
||
Item
1.
|
Financial
Statements (Unaudited)
|
3
|
a)
Condensed
Consolidated Statements of Income for the three months ended April 27,
2008 and April 29, 2007
|
3
|
|
b)
Condensed
Consolidated Balance Sheets as of April
27, 2008
and January 27, 2008
|
4
|
|
c)
Condensed
Consolidated Statements of Cash Flows for the three months ended
April
27, 2008 and April 29, 2007
|
5
|
|
d)
Notes
to Condensed
Consolidated
Financial Statements
|
6
|
|
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
24
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
34
|
Item
4.
|
Controls
and Procedures
|
35
|
PART
II :
OTHER INFORMATION
|
||
Item
1.
|
Legal
Proceedings
|
36
|
Item
1A.
|
Risk
Factors
|
36
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
49
|
Item
3.
|
Defaults
upon Senior Securities
|
50
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
50
|
Item
5.
|
Other
Information
|
50
|
Item
6.
|
Exhibits
|
51
|
Signatures
|
52
|
Three
Months Ended
|
||||||||
April 27,
2008
|
April
29,
2007
|
|||||||
Revenue
|
$
|
1,153,388
|
$
|
844,280
|
||||
Cost
of revenue
|
638,545
|
464,142
|
||||||
Gross
profit
|
514,843
|
380,138
|
||||||
Operating
expenses:
|
||||||||
Research
and development
|
218,830
|
158,321
|
||||||
Sales,
general and administrative
|
93,034
|
80,571
|
||||||
Total
operating expenses
|
311,864
|
238,892
|
||||||
Income
from operations
|
202,979
|
141,246
|
||||||
Interest
income
|
14,323
|
13,208
|
||||||
Other
expense, net
|
(4,284
|
)
|
(665
|
)
|
||||
Income
before income tax expense
|
213,018
|
153,789
|
||||||
Income
tax expense
|
36,213
|
21,530
|
||||||
Net
income
|
$
|
176,805
|
$
|
132,259
|
||||
Basic
income per share
|
$
|
0.32
|
$
|
0.24
|
||||
Shares
used in basic per share computation (1)
|
555,673
|
541,247
|
||||||
Diluted
income per share
|
$
|
0.30
|
$
|
0.22
|
||||
Shares
used in diluted per share computation (1)
|
591,989
|
598,299
|
April
27,
2008
|
January
27,
2008
|
|||||||
ASSETS
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$
|
803,308
|
$
|
726,969
|
||||
Marketable
securities
|
818,331
|
1,082,509
|
||||||
Accounts
receivable, net
|
651,800
|
666,494
|
||||||
Inventories
|
420,126
|
358,521
|
||||||
Prepaid
expenses and other
|
55,428
|
54,336
|
||||||
Total
current assets
|
2,748,993
|
2,888,829
|
||||||
Property
and equipment, net
|
522,056
|
359,808
|
||||||
Goodwill
|
371,019
|
354,057
|
||||||
Intangible
assets, net
|
125,001
|
106,926
|
||||||
Deposits
and other assets
|
40,389
|
38,051
|
||||||
Total
assets
|
$
|
3,807,458
|
$
|
3,747,671
|
||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable
|
$
|
427,855
|
$
|
492,099
|
||||
Accrued
liabilities
|
448,697
|
475,062
|
||||||
Total
current liabilities
|
876,552
|
967,161
|
||||||
Other
long-term liabilities
|
193,728
|
162,598
|
||||||
Commitments
and contingencies - see Note 12
|
||||||||
Stockholders’
equity:
|
||||||||
Preferred
stock
|
-
|
-
|
||||||
Common
stock
|
623
|
619
|
||||||
Additional
paid-in capital
|
1,727,519
|
1,654,681
|
||||||
Treasury
stock, at cost
|
(1,163,528
|
)
|
(1,039,632
|
)
|
||||
Accumulated
other comprehensive income
|
1,549
|
8,034
|
||||||
Retained
earnings
|
2,171,015
|
1,994,210
|
||||||
Total
stockholders' equity
|
2,737,178
|
2,617,912
|
||||||
Total
liabilities and stockholders' equity
|
$
|
3,807,458
|
$
|
3,747,671
|
||||
Three
Months Ended
|
||||||||
April
27,
2008
|
April 29,
2007
|
|||||||
Cash
flows from operating activities:
|
||||||||
Net
income
|
$
|
176,805
|
$
|
132,259
|
||||
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
||||||||
Stock-based
compensation expense related to employees
|
42,124
|
37,405
|
||||||
Depreciation
and amortization
|
41,358
|
31,334
|
||||||
Deferred
income taxes
|
31,186
|
899
|
||||||
Payments
under patent licensing arrangement
|
(4,980
|
) |
(11,291
|
)
|
||||
Other
|
1,238
|
60
|
||||||
Changes
in operating assets and liabilities, net of effects of
acquisitions:
|
||||||||
Accounts
receivable
|
15,826
|
47,847
|
||||||
Inventories
|
(61,149
|
) |
22,840
|
|||||
Prepaid
expenses and other current assets
|
(831
|
) |
(2,642
|
)
|
||||
Deposits
and other assets
|
(2,258
|
) |
1,376
|
|||||
Accounts
payable
|
(68,608
|
) |
61,344
|
|||||
Accrued
liabilities and other long-term liabilities
|
(25,466
|
) |
(26,233
|
)
|
||||
Net
cash provided by operating activities
|
145,245
|
295,198
|
||||||
Cash
flows from investing activities:
|
||||||||
Purchases
of marketable securities
|
(289,649
|
) |
(268,211
|
)
|
||||
Proceeds
from sales and maturities of marketable securities
|
545,803
|
214,775
|
||||||
Purchases
of property and equipment and intangible assets
|
(202,173
|
) |
(26,336
|
)
|
||||
Acquisition
of businesses, net of cash and cash equivalents
|
(27,948
|
) |
-
|
|||||
Other
|
(1,500
|
) |
-
|
|||||
Net
cash used in investing activities
|
24,533
|
(79,772
|
)
|
|||||
Cash
flows from financing activities:
|
||||||||
Payments
for stock repurchases
|
(123,896
|
) |
(125,000
|
)
|
||||
Proceeds
from issuance of common stock under employee stock
plans
|
30,457
|
44,111
|
||||||
Net
cash used in financing activities
|
(93,439
|
) |
(80,889
|
)
|
||||
Change
in cash and cash equivalents
|
76,339
|
134,537
|
||||||
Cash
and cash equivalents at beginning of period
|
726,969
|
544,414
|
||||||
Cash
and cash equivalents at end of period
|
$
|
803,308
|
$
|
678,951
|
||||
Supplemental
disclosures of cash flow information:
|
||||||||
Cash
paid for income taxes, net
|
$
|
1,982
|
$
|
1,916
|
||||
Other
non-cash activities:
|
||||||||
Unrealized
losses from marketable securities
|
$
|
8,234
|
$
|
213
|
Three
Months Ended
|
||||||||
April
27,
2008
|
April
29,
2007
|
|||||||
(In
thousands)
|
||||||||
Cost
of revenue
|
$
|
3,136
|
$
|
2,809
|
||||
Research
and development
|
24,534
|
22,400
|
||||||
Sales,
general and administrative
|
14,454
|
12,196
|
||||||
Total
|
$
|
42,124
|
$
|
37,405
|
Three
Months Ended
|
|||||||
April 27,
2008
|
April 29,
2007
|
||||||
Stock Options | (Using a binomial model) | ||||||
Weighted
average expected life of stock options (in years)
|
3.6
- 5.7
|
3.9
- 5.8
|
|||||
Risk
free interest rate
|
2.6%
- 2.9
|
%
|
4.6
|
%
|
|||
Volatility
|
60%
- 68
|
%
|
39%
- 45
|
%
|
|||
Dividend
yield
|
—
|
—
|
Three
Months Ended
|
|||||||
April 27,
2008
|
April 29,
2007
|
||||||
Employee Stock Purchase Plan | (Using a Black-Scholes model) | ||||||
Weighted
average expected life of stock options (in years)
|
0.5
- 2.0
|
0.5
– 2.0
|
|||||
Risk
free interest rate
|
1.6%
- 1.8
|
%
|
4.6%
- 5.0
|
%
|
|||
Volatility
|
68
|
%
|
47
|
%
|
|||
Dividend
yield
|
—
|
—
|
Options
Available for Grant
|
Options
Outstanding
|
Weighted
Average Exercise Price Per Share
|
||||||||||
Balances,
January 27, 2008
|
44,044,004
|
90,581,073
|
$
|
13.18
|
||||||||
Granted
|
(8,729,705
|
)
|
8,729,705
|
$
|
18.21
|
|||||||
Exercised
|
-
|
(2,531,463
|
)
|
$
|
4.77
|
|||||||
Cancelled
|
502,017
|
(502,017
|
)
|
$
|
22.80
|
|||||||
Balances,
April 27, 2008
|
35,816,316
|
96,277,298
|
$
|
13.81
|
Three
Months Ended
|
||||||||
April
27,
2008
|
April
29,
2007
|
|||||||
(In
thousands, except per share data)
|
||||||||
Numerator:
|
||||||||
Net
income
|
$
|
176,805
|
$
|
132,259
|
||||
Denominator:
|
||||||||
Denominator
for basic net income per share, weighted average shares
|
555,673
|
541,247
|
||||||
Effect
of dilutive securities:
|
||||||||
Stock
options outstanding
|
36,316
|
57,052
|
||||||
Denominator
for diluted net income per share, weighted average shares
|
591,989
|
598,299
|
||||||
Net
income per share:
|
||||||||
Basic
net income per share
|
$
|
0.32
|
$
|
0.24
|
||||
Diluted
net income per share
|
$
|
0.30
|
$
|
0.22
|
|
Fair
Market Value
|
Straight-Line
Amortization Period
|
||||||
(In
thousands)
|
(Years)
|
|||||||
Property
and equipment
|
$
|
2,433
|
1-2
|
|||||
Trademarks
|
11,310
|
5
|
||||||
Goodwill
|
85,418
|
--
|
||||||
Total
|
$
|
99,161
|
Mental
Images
|
Ageia
|
|||||||
Fair
Market Values
|
(In thousands) | |||||||
Cash
and cash equivalents
|
$
|
988
|
$
|
1,744
|
||||
Marketable
Securities
|
-
|
28
|
||||||
Accounts
receivable
|
1,462
|
911
|
||||||
Prepaid
and other current assets
|
249
|
3,825
|
||||||
Property
and equipment
|
1,376
|
166
|
||||||
In-process
research and development
|
4,000
|
-
|
||||||
Goodwill
|
63,290
|
16,758
|
||||||
Intangible
assets:
|
||||||||
Existing technology
|
14,400
|
13,450
|
||||||
Customer relationships
|
6,500
|
170
|
||||||
Patents
|
5,000
|
-
|
||||||
Trademark
|
1,200
|
900
|
||||||
Total
assets acquired
|
98,465
|
37,952
|
||||||
Current
liabilities
|
(6,395
|
)
|
(7,232
|
)
|
||||
Acquisition
related costs
|
(1,208
|
)
|
(1,000
|
)
|
||||
Long-term
liabilities
|
(2,542
|
)
|
-
|
|||||
Total
liabilities assumed
|
(10,145
|
)
|
(8,232
|
)
|
||||
Net
assets acquired
|
$
|
88,320
|
$
|
29,720
|
||||
Mental
Images
|
Ageia
|
||||||
(Straight-line
depreciation/amortization period)
|
|||||||
Property
and equipment
|
2
-5 years
|
1-2
years
|
|||||
Intangible
assets:
|
|||||||
Existing
technology
|
4-5
years
|
4
years
|
|||||
Customer
relationships
|
4-5
years
|
5
years
|
|||||
Patents
|
5
years
|
-
|
|||||
Trademark
|
5
years
|
5
years
|
April 27,
2008
|
January 27,
2008
|
|||||||
(In
thousands)
|
||||||||
3dfx
|
$
|
75,326
|
$
|
75,326
|
||||
MediaQ
|
35,167
|
35,167
|
||||||
ULi
|
31,115
|
31,115
|
||||||
Hybrid
Graphics
|
27,906
|
27,906
|
||||||
PortalPlayer
|
104,473
|
104,473
|
||||||
Mental
Images
|
63,290
|
63,086
|
||||||
Ageia
|
16,758
|
-
|
||||||
Other
|
16,984
|
16,984
|
||||||
Total
goodwill
|
$
|
371,019
|
$
|
354,057
|
April
27, 2008
|
January 27, 2008
|
|||||||||||||||||||||||
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Net Carrying
Amount
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Net Carrying
Amount
|
|||||||||||||||||||
(In
thousands)
|
||||||||||||||||||||||||
Technology
licenses
|
$
|
90,562
|
$
|
(25,865
|
)
|
$
|
64,697
|
$
|
94,970
|
$
|
(32,630
|
)
|
$
|
62,340
|
||||||||||
Patents
|
12,183
|
(5,095
|
)
|
7,088
|
35,348
|
(27,632
|
)
|
7,716
|
||||||||||||||||
Acquired
intellectual property
|
75,030
|
(21,814
|
)
|
53,216
|
77,900
|
(41,030
|
)
|
36,870
|
||||||||||||||||
Other
|
-
|
-
|
-
|
1,494
|
(1,494
|
)
|
-
|
|||||||||||||||||
Total intangible
assets
|
$
|
177,775
|
$
|
(52,774
|
)
|
$
|
125,001
|
$
|
209,712
|
$
|
(102,786
|
)
|
$
|
106,926
|
April 27,
2008
|
January 27,
2008
|
|||||||
Inventories:
|
(In
thousands)
|
|||||||
Raw
materials
|
$
|
31,307
|
$
|
31,299
|
||||
Work
in-process
|
162,386
|
107,835
|
||||||
Finished
goods
|
226,433
|
219,387
|
||||||
Total
inventories
|
$
|
420,126
|
$
|
358,521
|
April 27,
2008
|
January 27,
2008
|
|||||||
Accrued
Liabilities:
|
(In thousands) | |||||||
Accrued
customer programs (1)
|
$
|
261,589
|
$
|
271,869
|
||||
Accrued
payroll and related expenses
|
88,420
|
122,284
|
||||||
Accrued
legal settlement (2)
|
30,600
|
30,600
|
||||||
Deferred
rent
|
11,825
|
11,982
|
||||||
Taxes
payable
|
8,898
|
7,766
|
||||||
Deferred
revenue
|
14,708
|
5,856
|
||||||
Other
|
32,657
|
24,705
|
||||||
Total accrued
liabilities
|
$
|
448,697
|
$
|
475,062
|
April 27,
2008
|
January 27,
2008
|
|||||||
Other
Long-term Liabilities:
|
(In
thousands)
|
|||||||
Deferred
income tax liability
|
$
|
114,596
|
$
|
86,900
|
||||
Income
taxes payable, long term
|
49,628
|
44,235
|
||||||
Asset
retirement obligation
|
6,534
|
6,470
|
||||||
Other
long-term liabilities
|
22,970
|
24,993
|
||||||
Total other long-term
liabilities
|
$
|
193,728
|
$
|
162,598
|
April
27,
2008
|
April
29,
2007
|
|||||||
(In
thousands)
|
||||||||
Balance at
beginning of period
|
$
|
24,432
|
$
|
17,958
|
||||
Additions (1)
|
9,550
|
4,980
|
||||||
Deductions (2)
|
(8,882
|
)
|
(3,875
|
)
|
||||
Balance at
end of period (3)
|
$
|
25,100
|
$
|
19,063
|
|
(1)
Includes $8,865 and $4,746 for the three months ended April
27, 2008 and April 29, 2007, respectively, towards allowances for sales
returns estimated at the time revenue is recognized primarily based on
historical return rates and is charged as a reduction to
revenue.
(2) Includes
$8,882 and $3,875 for the three months ended April 27, 2008 and April 29,
2007, respectively, written off against the allowance for sales
returns.
(3) Includes
$18,708 and $15,348 at April 27, 2008 and April 29, 2007, respectively,
relating to allowance for sales
returns.
|
Three
Months Ended
|
||||||||
April
27,
2008
|
April
29,
2007
|
|||||||
(In
thousands)
|
||||||||
Net
income
|
$
|
176,805
|
$
|
132,259
|
||||
Net
change in unrealized gains on available-for-sale securities, net of
tax
|
(5,631
|
)
|
(79
|
)
|
||||
Reclassification
adjustments for net realized gains on available-for-sale securities
included in net income, net of tax
|
(854
|
)
|
(73
|
)
|
||||
Total
comprehensive income
|
$
|
170,320
|
$
|
132,107
|
GPU
|
PSB
|
MCP
|
CPB
|
All
Other
|
Consolidated
|
|||||||||||||||||||
(In
thousands)
|
||||||||||||||||||||||||
Three
Months Ended April 27, 2008:
|
||||||||||||||||||||||||
Revenue
|
$
|
701,489
|
$
|
203,427
|
$
|
195,093
|
$
|
42,465
|
$
|
10,914
|
$
|
1,153,388
|
||||||||||||
Depreciation
and amortization expense
|
$
|
12,714
|
$
|
4,625
|
$
|
7,670
|
$
|
4,918
|
$
|
11,641
|
$
|
41,568
|
||||||||||||
Operating
income (loss)
|
$
|
169,047
|
$
|
110,328
|
$
|
3,580
|
$
|
(3,850
|
)
|
$
|
(76,126
|
)
|
$
|
202,979
|
||||||||||
Three
Months Ended April 29, 2007:
|
||||||||||||||||||||||||
Revenue
|
$
|
483,495
|
$
|
140,873
|
$
|
148,750
|
$
|
67,226
|
$
|
3,936
|
$
|
844,280
|
||||||||||||
Depreciation
and amortization expense
|
$
|
8,285
|
$
|
2,187
|
$
|
6,593
|
$
|
6,095
|
$
|
9,162
|
$
|
32,322
|
||||||||||||
Operating
income (loss)
|
$
|
124,417
|
$
|
69,307
|
$
|
7,839
|
$
|
10,168
|
$
|
(70,485
|
)
|
$
|
141,246
|
Three
Months Ended
|
||||||||
April
27,
2008
|
April
29,
2007
|
|||||||
Revenue:
|
(In
thousands)
|
|||||||
Taiwan
|
$
|
391,628
|
$
|
272,983
|
||||
China
|
367,426
|
238,285
|
||||||
Other
Asia Pacific
|
167,854
|
109,930
|
||||||
United
States
|
93,831
|
101,866
|
||||||
Europe
|
131,954
|
81,550
|
||||||
Other
Americas
|
695
|
39,666
|
||||||
Total
revenue
|
$
|
1,153,388
|
$
|
844,280
|
Three
Months Ended
|
||||||||
April 27,
2008
|
April 29,
2007
|
|||||||
Revenue: | ||||||||
Customer
A
|
11 | % | 9 | % |
April 27,
2008
|
January 27,
2008
|
||||||
Accounts Receivable: | |||||||
Customer
A
|
11
|
%
|
12
|
%
|
|||
Customer
B
|
11
|
%
|
6
|
%
|
|||
Customer
C
|
10
|
%
|
9
|
%
|
Fair
value measurement at reporting date using
|
||||||||||||
Quoted Prices in
Active Markets for Identical Assets
|
Significant
Other Observable Inputs
|
|||||||||||
April
27, 2008
|
(Level
1)
|
(Level
2)
|
||||||||||
(In
thousands)
|
||||||||||||
Asset-backed
Securities (1)
|
$
|
88,255
|
$
|
-
|
$
|
88,255
|
||||||
Commercial
paper (2)
|
250,365
|
-
|
250,365
|
|||||||||
Corporate
debt securities (3)
|
274,273
|
-
|
274,273
|
|||||||||
Debt
securities issued by United States Treasury (1)
|
33,487
|
-
|
33,487
|
|||||||||
Other
Debt securities issued by US Government agencies (4)
|
297,993
|
-
|
297,993
|
|||||||||
Mortgage-backed
securities issued by Government-sponsored entities (1)
|
70,172
|
-
|
70,172
|
|||||||||
Money
market funds (5)
|
304,774
|
304,774
|
-
|
|||||||||
Equity
securities (1)
|
3,357
|
-
|
3,357
|
|||||||||
Total
assets
|
$
|
1,322,676
|
$
|
304,774
|
$
|
1,017,902
|
(1)
|
Included
in Marketable Securities on the Condensed Consolidated Balance
Sheet.
|
(2)
|
Includes
$177,410 in Cash and cash equivalents and $72,955 in Marketable Securities
on the Condensed Consolidated Balance
Sheet.
|
(3)
|
Includes
$1,520 in Cash and cash equivalents and $272,753 in Marketable Securities
on the Condensed Consolidated Balance
Sheet.
|
(4)
|
Includes
$20,640 in Cash and cash equivalents and $277,353 in Marketable Securities
on the Condensed Consolidated Balance
Sheet.
|
(5)
|
Included
in Cash and cash equivalents on the Condensed Consolidated Balance
Sheet.
|
Three
Months Ended
|
|||||||
April 27,
2008
|
April
29,
2007
|
||||||
Revenue
|
100.0
|
%
|
100.0
|
%
|
|||
Cost
of revenue
|
55.4
|
55.0
|
|||||
Gross
profit
|
44.6
|
45.0
|
|||||
Operating
expenses:
|
|||||||
Research
and development
|
19.0
|
18.8
|
|||||
Sales,
general and administrative
|
8.1
|
9.5
|
|||||
Total
operating expenses
|
27.1
|
28.3
|
|||||
Income
from operations
|
17.5
|
16.7
|
|||||
Interest
and other income, net
|
0.9
|
1.5
|
|||||
Income
before income tax expense
|
18.4
|
18.2
|
|||||
Income
tax expense
|
3.1
|
2.6
|
|||||
Net
income
|
15.3
|
%
|
15.6
|
%
|
Three
Months Ended
|
|||||||||||||||
April
27,
2008
|
April
29,
2007
|
$
Change
|
%
Change
|
||||||||||||
(In
millions)
|
|||||||||||||||
Research
and development expenses
|
$
|
218.8
|
$
|
158.3
|
$
|
60.5
|
38
|
%
|
|||||||
Sales,
general and administrative expenses
|
93.1
|
80.6
|
12.5
|
16
|
%
|
||||||||||
Total
operating expenses
|
$
|
311.9
|
$
|
238.9
|
$
|
73.0
|
31
|
%
|
|||||||
Research
and development as a percentage of net revenue
|
19
|
%
|
19
|
%
|
|||||||||||
Sales,
general and administrative as a percentage of net
revenue
|
8
|
%
|
10
|
%
|
As
of
April
27, 2008
|
As
of
January
27, 2008
|
|||||||
(In
millions)
|
||||||||
Cash
and cash equivalents
|
$ | 803.3 | $ | 727.0 | ||||
Marketable
securities
|
818.3 | 1,082.5 | ||||||
Cash,
cash equivalents, and marketable securities
|
$ | 1,621.6 | $ | 1,809.5 |
Three
Months Ended
|
||||||||
April
27,
|
April
29,
|
|||||||
2008
|
2007
|
|||||||
(In
millions)
|
||||||||
Net
cash provided by operating activities
|
$
|
145.2
|
$
|
295.2
|
||||
Net
cash used in investing activities
|
$
|
24.5
|
$
|
(79.8
|
)
|
|||
Net
cash used in financing activities
|
$
|
(93.4
|
)
|
$
|
(80.9
|
)
|
·
|
decreased
demand and market acceptance for our products and/or our customers’
products;
|
·
|
inability
to successfully develop and produce in volume production our
next-generation products;
|
·
|
competitive
pressures resulting in lower than expected average selling prices;
and
|
·
|
new
product announcements or product introductions by our
competitors.
|